|
1
|
Herce DH, Deng W, Helma J, Leonhardt H and
Cardoso MC: Visualization and targeted disruption of protein
interactions in living cells. Nat Commun. 4:26602013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vousden KH and Lu X: Live or let die: The
cell's response to p53. Nat Rev Cancer. 2:594–604. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davidson RW, Kari C, Ren Q, Daroczi B,
Dicker PA and Rodeck U: Differential regulation of p53 function by
the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos. BMC
Dev Biol. 10:1022010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song W, Huo SW, Lü JJ, Liu Z, Fang XL, Jin
XB and Yuan MZ: Expression of p53 isoforms in renal cell carcinoma.
Clim Med J (Engl). 122:921–926. 2009.
|
|
5
|
Khoury MP and Bourdon C: p53 Isoforms. An
intracellular microprocessor? Genes Cancer. 2:453–465. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wel J, Zaika E and Zaika A: p53 Family:
Role of protein isoforms in human cancer. J Nucleic Acids.
2012:6873592012.PubMed/NCBI
|
|
7
|
Teodoro JG, Evans SK and Green MR:
Inhibition of tumour angiogenesis by p53: A new role for the
guardian of the genome. J Mol Med (Berl). 85:1175–1186. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bernard H, Garmy-Susini B, Ainaoui N, Van
Den Berghe L, Peurichard A, Javerzat S, Bikfalvi A, Lane DP,
Bourdon JC and Prats AC: The p53 isoform, Δ133p53α, stimulates
angiogenesis and tumour progression. Oncogene. 32:2150–2160. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kouidou S, Malousi A, Kyventidis A, Fragou
A and Maglaveras N: G:C>A:T mutations and potential epigenetic
regulation of p53 in breast cancer. Breast Cancer Res Treat.
106:351–360. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pekova S, Cmejla R, Smolej L, Kozak T,
Spacek M and Prucha M: Identification of a novel,
transactivation-defective splicing variant of p53 gene in patients
with chronic lymphocytic leukemia. Leuk Res. 32:395–400. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ute M and Petrenko O: The MDM2-p53
interaction. Mol Cancer Res. 1:1001–1008. 2003.PubMed/NCBI
|
|
12
|
Freedman DA and Lavine AJ: Nuclear export
is required for degradation of endogenous p53 by MDM2 and human
papillomavirus E6. Mol Cell Biol. 18:7288–7293. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Itahana K, Mao H, Jin A, Itahana Y, Clegg
H, Lindström MS, Bhat KP, Godfrey VL, Evan GI and Zhang Y: Targeted
inactivation of Mdm2 Ring finger E3 ubiquitin ligase activity in
the mouse reveals mechanistic insights into p53 regulation. Cancer
Cell. 12:355–366. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiong Y, Hannon GJ, Zhang H, Casso D,
Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin
kinases. Nature. 366:701–704. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guimaraes DP and Hainaut P: TP53: A key
gene in human cancer. Biochimie. 84:83–93. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun P, Qiu Y, Zhang Z, Wan J, Wang T, Jin
X, Lan Q, Rothman N and Xia ZL: Association of genetic
polymorphisms, mRNA expression of p53 and p21 with chronic benzene
poisoning in a Chinese occupational population. Cancer Epidemiol
Biomarkers Prev. 18:1821–1828. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pfaffl MW, Graham WH and Dempfle L:
Relative expression software tool (REST) for group-wise comparison
and statistical analysis of relative expression results in
real-time PCR. Nucl Acids Res. 30:e362002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Welinder C and Ekblad L: Coomassie
staining as loading control in Western blot analysis. J Proteome
Res. 10:1416–1419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hofstetter G, Berger A, Schuster E, Wolf
A, Hager G, Vergote I, Cadron I, Sehouli J, Braicu EI, Mahner S, et
al: Δ133p53 is an independent prognostic marker in p53 mutant
advanced serous ovarian cancer. Br J Cancer. 105:1593–709. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moore CH, Jordan BL, Bray ES, Baker L,
Quinlan RP, Purdie CA, Thompson AM, Bourdon JC and Fuller-Pace FV:
The RNA helicase p68 modulates expression and function of the Δ133
isoform(s) of p53, and is inversely associated with Δ133p53
expression in breast cancer. Oncogene. 29:6475–6484. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dewing AS, Rueli RH, Robles MJ, Nguyen-Wu
ED, Zeyda T, Berry MJ and Bellinger FP: Expression and regulation
of mouse selenoprotein P transcript variants differing in
non-coding RNA. RNA Biol. 9:1361–1369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Keene JD: RNA regulons: Coordination of
post-transcriptional events. Nat Rev Gene. 8:533–543. 2007.
View Article : Google Scholar
|
|
24
|
Chen J, Ng SM, Chang C, Zhang Z, Bourdon
JC, Lane DP and Peng J: p53 isoform D113p53 is a p53 target gene
that antagonizes p53 apoptotic activity via BclxL activation in
zebrafish. Genes Dev. 23:278–290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gong L, Gong H, Pan X, Chang C, Ou Z, Ye
S, Yin L, Yang L, Tao T, Zhang Z, et al: p53 isoform
Δ113p53/Δ133p53 promotes DNA double-strand break repair to protect
cell from death and senescence in response to DNA damage. Cell Res.
25:351–369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leppert U and Eisenreich A: The role of
tissue factor isoforms in cancer biology. Int J Cancer.
137:497–503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Goldin-Lang P, Tran QV, Fichtner I,
Eisenreich A, Antoniak S, Schulze K, Coupland SE, Poller W,
Schultheiss HP and Rauch U: Tissue factor expression pattern in
human non-small cell lung cancer tissues indicate increased blood
thrombogenicity and tumour metastasis. Oncol Rep. 20:123–128.
2008.PubMed/NCBI
|
|
28
|
Eisenreich A, Zakrzewicz A, Huber K,
Thierbach H, Pepke W, Goldin-Lang P, Schultheiss HP, Pries A and
Rauch U: Regulation of pro-angiogenic tissue factor expression in
hypoxia-induced human lung cancer cells. Oncol Rep. 30:462–470.
2013.PubMed/NCBI
|
